Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 090849
Company: SANDOZ
Company: SANDOZ
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
OXALIPLATIN | OXALIPLATIN | 50MG/VIAL | INJECTABLE;INTRAVENOUS | Discontinued | None | No | No |
OXALIPLATIN | OXALIPLATIN | 100MG/VIAL | INJECTABLE;INTRAVENOUS | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/28/2011 | ORIG-1 | Approval |
Review (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/anda/2011/090849Orig1s000Approv.pdf |